Expert Interview
A Second Opinion: Discussing the potential use of Thermo Fisher Scientific Inc's new blood test to detect women with risk of severe preeclampsia
Ticker(s): TMOInstitution: Penn State University
- Professor of Obstetrics and Gynecology and Radiology at Penn State.
- Manages 50+ patients at risk for preeclampsia.
- Clinical interest in Amniocentesis, Obstetrical ultrasound, and Prenatal diagnosis.
Describe your background and practice setting
Added By: ben_adminHow many patients do you manage who are at risk for preeclampsia?
Added By: ben_adminWhat is the current gold standard for testing for preeclampsia?
Added By: ben_adminWhat are your thoughts on the test from Thermo Fisher?
Added By: ben_adminHow do you interpret the tests sensitivity and specificity results?
Added By: ben_adminHow many patients would you expect to order this test for in the first 6 months?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
